|
Abstract
Background:
For almost a hundred years homeopaths have attempted to
demonstrate the existence of the "potency effect"
scientifically. The general implication of all this work is that
highly dilute solutions (Homoeopathic potencies) do have effects
that can be demonstrated in carefully controlled laboratory
experiments.
The present study aims to evaluate the effects of high potency
in experimental animal and to evaluate the effects of 3x, 30c
and 0/3 potencies of Matricaria Chamomilla on Central
Nervous System.
Methods:
The blind screening methodologies, well known in modern Psycho-
Neuro pharmacology (Acto-
photometer, Rota – rod apparatus, Eddy’s Hot plate, Maximal –
electro shock method)
were utilized for Central Nervous System action investigations.
Results:
The
results were statistically processed by Analysis of variance
test (ANOVA) to compare the effects on treatment groups before
and after treatment with control group and Dunnet’s t
test were used to determine the effect of each treatment against
control group.
The results shows that Matricaria chamomilla 0/3,
significantly reduce locomotor activity, exhibit muscle relaxant
activity, causing analgesia and shows anti-convulsant activity
than Matricaria chamomilla 3x and Matricaria
chamomilla 30c.
Conclusion:
This experimental study, revealed that high dilution when get
dynamised by the process of succussion can have a significant
effect on biological system.
The
central nervous system depression is significantly performed by
0/3 potencies than 3x and 30c.
(Keywords – Matricaria chamomilla, C.N.S stimulant/depressant
activity, muscle relaxant activity, Analgesic activity, Anti
convulsant activity)
Introduction
The
purpose of fundamental research is to describe and possibly to
understand the phenomena purported by homoeopathy, using the
experimental method. Experimental method is based on the
assumption that any hypothesis should be testable, i. e.
measurements can be done to prove or disprove it. To do this, we
need specific and carefully selected experimental models.
Similar to clinical study, laboratory research is able to
show biological activity of homeopathic remedies that cannot be
explained as a placebo response. Laboratory research is also
capable of shedding some new light on how the homeopathic
remedies may work. This study intended to verify the effect of
Matricaria Chamomilla in various potencies on central
nervous system of experimental animal and it may help to
understand the biological phenomenon of the high potencies.
Aims and Objectives
-
To evaluate the
effects of high potency in Experimental Animal.
-
To evaluate the
effects of 3x, 30c and 0/3 potencies of Matricaria
chamomilla on Central nervous system.
Materials and Methods
Materials:
Plant: Matricaria chamomilla
The
Plant, Matricaria chamomilla was collected from Ooty
under the supervision of Dr.D.Suresh Baburaj, Survey Officer,
Medicinal plants survey and collection unit, Central Council for
Research in Homoeopathy, Ooty, India. The mother tincture of
Matricaria chamomilla was extracted as per the directions
given in Homoeopathic Pharmacopoeia of India (Vol- 5,
1986)1. The 3x and 30c potency of Matricaria
chamomilla were prepared with acqua distillata and 0/3
potency of Matricaria chamomilla brought from a reputed
firm, which were used in this experiment.
Animals:
Male
albino mice (Swiss strain) were procured from Sri Venkateswara
Enterprises, Bangalore, India and bred in the animal house of
Vinayaka Mission’s College of Pharmacy, Salem, India. They were
fed on commercial diet and water adlibitum during the
experiments. The pellet food containing 22.5% protein, 72.55%
carbohydrate, 5% fat and sufficient vitamins and minerals. The
cages were placed in well-ventilated place in the laboratory and
were provided with 1.5 inches rice-bran bedding which was
changed every day. The room temperature was maintained at 25+
1oc . The animals were selected randomly. The study
was approved by Institutional Animal Ethical Committee of
Vinayaka Mission’s college of pharmacy, Salem, South India. Five
groups (I-V), each comprising of six animals weighing between
(20-25g) were selected.
GROUP-I -Control group without any treatment
GROUP-II - Group treated with standard drugs (Dose
according to drugs used)
GROUP III - Group treated with Matricaria chamomilla
3x,
10 ml/Kg/ p.o, four times/ day
for one day.
GROUP IV- Group treated with Matricaria chamomilla
30c,
10 ml/Kg/ p.o, two times/ day
for three days.
GROUP V- Group treated with Matricaria chamomilla
0/3,
10 ml/Kg/ p.o, two times/ day
for three days.
The
test was made three hours after the latest administration of
drug.
Screening Methods for C.N.S Depressant Drugs.
The
blind screening methodology, well known in Psyco-Neuro
pharmacology was utilized for Central Nervous System actions
investigations.
A) Rota rod with compartments – muscle relaxant property2,
3:
First
the animal is trained to stand on the rotating rod at slow
speeds. Once the animal is trained the platform where the
animal will fall is lifted slightly upward to restart the
counter. After the counter is switched on the animal will
keep on balancing on the rotating rod and at one stage it will
fall on the platform and at this stage the counter will stop.
The time is noted directly in seconds from the counter.
The cut off time to animals to fall from the rotating rod at a
recommended speed is fixed at (120 Sec) and those animals stay
on the rotating rod more than the cutoff time are discarded from
the study.
The same experiment is repeated at
different speeds of the rod and also after administering
suitable drug to the animal. There is a reset button provided
by the side of each counter that is used to reset the counter to
Zero after each record is taken. The complete setup is designed
to work under 230 V 50 Hz.A.C.
The
endurance time in seconds before and after the drug
administration is recorded from digital counter. Those animals
which fall off from the rod after administration of test drug
(e.g. Muscle relaxant drugs) show adjustment difficulty to stand
on the rotating rod. This indirectly shows the muscle weakness
and inco-ordination of the animals due to the relaxation of
skeletal muscles. The drugs with muscle relaxant activity
(Central/Peripheral), Sedatives, Anxiolytic drugs (Diazepam
type) will show lesser time of standing when compared to
pretreatment.
B) Eddy’s hot plate – Analgesic activity4:
In
this method heat is used as a source of pain. Animals are
individually placed on a hot plate maintained at constant
temperature (55◦C) and the reaction of animals, such
as paw licking or jump response is taken as the end point.
Analgesics increase the reaction – time.
C) Acto- photo meter – C.N.S stimulant/depressant activity5,
6:
1. The
instrument consists of a cage which is 30 cm long and 30 cm
deep. It has wire mesh at the bottom.
2.
Six lights and 6 photocells are placed in the outer periphery of
the bottom in such a way that a single mouse can block only
one beam.
3.
Technically its principle is that a photocell is activated when
the rays of light failing on photocells are cut off by animals
crossing the beam of light.
4.
Photocells are connected to an electronic automatic counter
device which counts the number of “cutoffs”.
D) Maximal electro - shock method (M.E.S) – Anti convulsant
activity7,
8:
The
maximal electro – shock (M.E.S) induced convulsions in animal
represent grand mal type of epilepsy. In M.E.S convulsions
electric shock is applied through the corneal electrodes.
Through optic stimulation cortical excitation is produced. The
M.E.S convulsions are divided into five phases such as tonic
flexion, tonic extension, clonic convulsion, stupor and recovery
or death. Note the time (in seconds) spent by the animal in each
phase of convulsions. A substance is known to possess
anticonvulsant property if it reduces or abolishes the extensor
phase of M.E.S convulsions. This procedure may be used to
produce convulsion both in rats and mice. For rat, 150 mA
current is applied for 0.2 seconds and for mice 50 mA current is
applied for 0.2 seconds.
Statistical Analysis
The results were statistically processed by
Analysis of variance test (ANOVA) to compare the effects on
treatment groups before and after treatment with control group
and Dunnet’s t test were used to determine the effect of
each treatment against control group.
The null hypothesis (H0) was
assumed that there was no difference in effects of treatments
between the treatment groups compared with control group and
alternate hypothesis (H1) was assumed there was
significant difference in effect of treatment between the
treatment groups compared with control group.
Observation
The
mice of untreated, control group showed restless, hyper motility
and fast climbing behaviour.
The
mice treated with standard drug group did not show greed for
eating and drinking. They drank very small quantity of water
during the experiment. They showed a decrease in locomotor
activity and quietness.
The
mice treated with Matricaria Chamomilla 3x showed
hypomotility, increased threshold to pain stimuli, decreased
muscle grip and decreased extensor phase in convulsions.
The
mice treated with Matricaria Chamomilla 30c showed
reduced locomotor activity, increased threshold to pain stimuli,
decreased muscle grip and decreased extensor phase in
convulsions.
The
mice treated with Matricaria Chamomilla 0/3 showed
hypomotility, increased threshold to pain stimuli, decreased
muscle grip and decreased extensor phase in convulsions than
group treated with Matricaria Chamomilla 3x and
Matricaria Chamomilla 30c.
Result
Locomotor
activity
Before treatment:
From table 2, calculated F- value (1.92) is compared with table
F- value (4.18) with 4, 25 df at 1% level of significance.
Therefore the calculated F value is less than table F value. So
the null hypothesis is accepted and there is no significant
difference in the locomotor activity among the groups before
treatment.
After treatment:
From
table 3, calculated F- value (5.32) is compared with table F-
value (4.18) with 4, 25 df at 1% level of significance.
Therefore the calculated F value is greater than table F value.
So the null hypothesis is rejected and there is significant
difference in the locomotor activity among the groups after
treatment.
The standard drug, Phenobarbitone
sodium (40mg/Kg, i.p) reduce the locomotor activity by 65.39%
(P<0.001), Chamomilla 0/3 (10 ml/Kg, o.p) reduce the locomotor
activity by 46.54% (P<0.001), Chamomilla 30c (10 ml/Kg, o.p)
reduce the locomotor activity by 26.08% (P<0.001) and Chamomilla
3x (10 ml/Kg, o.p) reduce the locomotor activity by 18.25%
(P<0.001).
Muscle relaxant activity:
Before treatment:
From
the table 6, calculated F- value (1.09) is compared with table
F- value (4.18) with 4, 25 df at 1% level of significance.
Therefore the calculated F value is less than table F value. So
the null hypothesis is accepted and there is no significant
difference in the Muscle relaxant activity among the groups
before treatment.
After treatment:
From the table 7, calculated F-
value (7.09) is compared with table F- value (4.18) with 4, 25 df at 1% level of significance. Therefore the calculated F value
is greater than table F value. So the null hypothesis is
rejected and there is significant difference in the Muscle
relaxant activity among the groups after treatment.
The
standard drug, Diazepam (4mg/Kg, i.p) reduce the fall off time
by 49.65% (P<0.001), Chamomilla 3x (10 ml/Kg, o.p) reduce the
fall off time by 35.93% (P<0.001), Chamomilla 0/3 (10 ml/Kg,
o.p) reduce the fall off time by 16.53% (P<0.05) and Chamomilla
30c (10 ml/Kg, o.p) reduce the fall off time by 9.84% (P<0.05).
Analgesic activity:
Before
treatment:
From the table 10,
calculated F- value (2.72) is compared with table F- value
(4.18) with 4, 25 df at 1% level of significance. Therefore the
calculated F value is less than table F value. So the null
hypothesis is accepted and there is no significant difference in
the Analgesic activity among the groups before treatment.
After treatment:From
the table 11, calculated F- value (18.55) is compared with table
F- value (4.18) with 4, 25 df at 1% level of significance.
Therefore the calculated F value is greater than table F value.
So the null hypothesis is rejected and there is significant
difference in the Analgesic activity among the groups after
treatment.
The
standard drug, Pentazocine (5mg/Kg, i.p) increase the reaction
time by 65% (P<0.001), Chamomilla 0/3 (10 ml/Kg, o.p) increase
the reaction time by 49.03% (P<0.001), Chamomilla 3x (10 ml/Kg,
o.p) increase the reaction time by 46.51% (P<0.001) and
Chamomilla 30c (10 ml/Kg, o.p) increase the reaction time by
26.98% (P<0.001).
Anti- convulsant activity:
After treatment:
From the table 14, calculated F-
value (26.52) is compared with table F- value (4.18) with 4, 25 df at 1% level of significance. Therefore the calculated F value
is greater than table F value. So the null hypothesis is
rejected and there is significant difference in the Anti-Convulsant
activity among the groups after treatment.
The standard drug, Phenytoin (25mg/Kg,
i.p) decrease extensor phase to 1.5 seconds (P<0.001),
Chamomilla 0/3 (10 ml/Kg, o.p) decrease extensor phase to 4.3
seconds (P<0.001), Chamomilla 3x (10 ml/Kg, o.p) decrease
extensor phase to 6.5 seconds (P<0.001) and Chamomilla 30c (10
ml/Kg, o.p) decrease extensor phase to 6.83 seconds (P<0.001).
Discussion
In homoeopathy, Matricaria chamomilla
is used for unbearable colic and pains in different locations
accompanied by an excitation of central nervous system. It is
also used in convulsions consecutive to a state of furious
agitation. In short, it can be used to depress central nervous
system activities9.
The results of the present study show some
inhibitory effects of Chamomilla potencies on central nervous
system. The central nervous system depression is significantly
performed by 0/3 potencies than 3x and 30c.
Referring to the previous studies in this area,
an experimental pharmacological research performed by Guillemain
(1983) showed that, at 3c and 4c dilutions, the Chamomilla
significantly diminishes the number of fights in rats after
exposing to electric shock. The study also showed that
Chamomilla 3c and 4c decreased caffeine induced motor
hyperactivity in male rats10. Another study conducted
by Criestea (1996) Chamomilla 5c has a stimulatory action on
central nervous system of experimental animal with hypomotility.
This study also reveals that Chamomilla 30c has an inhibitory
effect on central nervous system activities of experimental
animal with hypermotility11. But the results of the
present study concurrent with the statement of Richard Hughes
that Chamomilla is one of those drugs whose effect of crude and
infinitesimal doses are about identical12
Table – 13
Anti-convulsant activity against Maximal Electro-shock-induced
Convulsions
|
Group |
Treatment |
Dose |
Flexion
(sec) |
Extensor
(sec) |
Clonus
(sec) |
Recovery/
Death
|
|
1 |
Control
|
10ml/kg
p.o |
2.3±0.12 |
9.6±0.8 |
1.6±0.21 |
136±3.98 |
|
2 |
Phenytoin
|
25mg/kg
i.p |
0.83±0.06 |
1.5±0.22 |
1.16±0.29 |
17.5±1.43 |
|
3 |
Chamomilla3x
|
10ml/kg
p.o |
2±0.25 |
6.5±0.72 |
1.5±0.22 |
142.5±6.64 |
|
4 |
Chamomilla30c
|
10ml/kg
p.o |
1.5±0.34 |
6.83±0.6 |
1.66±0.3 |
142.16±7.46 |
|
5 |
Chamomilla0/3
|
10ml/kg
p.o |
2±0.25 |
4.3±0.87 |
1.5±0.22 |
132.66±10.17 |
Number of animals used in each
group: 6
The results are in Mean±SEM
Table -
2
Analysis of variance table for locomotor activity before
treatment.
|
Source of variation |
df |
Sum of squares |
Mean sum of squares |
F-ratio |
F-table value |
|
Treatment
Error |
5-1=4
29- 4=25 |
9159.20
29712.17 |
2289.8
1188.48 |
1.92*** |
4.18 |
|
Total |
30- 1=29 |
38871.37 |
|
|
|
***P
> 0.01, df 4, 25.
Table – 3
Analysis of variance table for locomotor activity after
treatment.
|
Source of variation |
df |
Sum of squares |
Mean sum of squares |
F-ratio |
F-table value |
|
Treatment
Error |
5-1=4
29- 4=25 |
26276.13
30860.67 |
6569.03
1234.42 |
5.32*** |
4.18 |
|
Total |
30- 1=29 |
38871.37 |
|
|
|
***P
< 0.01, df 4, 25.
Table
- 5
Muscle relaxant
property-Rota-rod apparatus
|
Group |
Treatment |
Dose |
Fall off time in sec before treatment |
Fall off time in sec after
treatment |
% decrease
in time |
|
1 |
Control
|
10ml/kg
p.o |
345.83±18.79 |
349.16±22.08 |
0.96% |
|
2 |
Diazepam
|
4mg/kg
i.p |
312.5±10.68 |
157.33±13.11 |
49..65% |
|
3 |
Chamomilla3x
|
10ml/kg
p.o |
372±31.86 |
238.33±51.47 |
35.93% |
|
4 |
Chamomilla 30c
|
10ml/kg
p.o |
335.16±22.60 |
302.16±19.10 |
9.84% |
|
5 |
Chamomilla0/3
|
10ml/kg
p.o |
369±28.67 |
308±17.62 |
16.53% |
Number of animals used in
each group: 6
The results are in
Mean±SEM
Table
- 6
Analysis of variance table for Muscle relaxant activity
before treatment.
|
Source of variation |
df |
Sum of squares |
Mean sum of squares |
F-ratio |
F-table value |
|
Treatment
Error |
5-1=4
29- 4=25 |
14643.53
83825.17 |
3660.88
3353.01 |
1.09*** |
4.18 |
|
Total |
30- 1=29 |
98468.7 |
|
|
|
***P
> 0.01, df 4, 25.
Table – 7
Analysis of variance table for Muscle relaxant activity
after
treatment.
|
Source of variation |
df |
Sum of squares |
Mean sum of squares |
F-ratio |
F-table value |
|
Treatment
Error |
5-1=4
29- 4=25 |
134625.66
118640.34 |
33656.42
4745.61 |
7.09*** |
4.18 |
|
Total |
30- 1=29 |
253266 |
|
|
|
***P
< 0.01, df 4, 25.
Table - 8
Dunnet’s t test table against control for
Muscle relaxant activity
|
Statistic |
Diazepam |
Chamomilla 3x
|
Chamomilla 30c
|
Chamomilla 0/3
|
|
t |
10.78****
|
6.23**** |
2.64** |
2.31** |
****P
< 0.001, **P < 0.05, df 25
Table – 9
Analgesic effect – Eddy’s hot
plate
|
Group |
Treatment |
Dose |
Basal reaction time. (sec) |
Reaction time after treatment.(sec) |
% increase
in reaction time |
|
1 |
Control
|
10ml/kg
p.o |
4.66±0.33 |
4.5±0.22 |
3.55% |
|
2 |
Pentazocine
|
5mg/kg
i.p |
3.5±0.22 |
10±0.73 |
65% |
|
3 |
Chamomilla3x
|
10ml/kg
p.o |
4.3±0.21 |
6.3±0.44 |
46.51% |
|
4 |
Chamomilla30c
|
10ml/kg
p.o |
4.6±0.33 |
6.3±0.42 |
26.98% |
|
5 |
Chamomilla0/3 |
10ml/kg
p.o |
4.5±0.34 |
8.83±0.47 |
49.03% |
Number of animals used in
each group: 6
The results are in
Mean±SEM
Table - 10
Analysis of variance table for Analgesic activity
before treatment.
|
Source of variation |
df |
Sum of squares |
Mean sum of squares |
F-ratio |
F-table value |
|
Treatment
Error |
5-1=4
29- 4=25 |
5.67
13 |
1.417
0.52 |
2.72*** |
4.18 |
|
Total |
30- 1=29 |
18.27 |
|
|
|
***P
> 0.01, df 4, 25.
Table - 11
Analysis of variance table for Analgesic activity
after treatment.
|
Source of variation |
df |
Sum of squares |
Mean sum of squares |
F-ratio |
F-table value |
|
Treatment
Error |
5-1=4
29- 4=25 |
115.8
39 |
28.95
1.56 |
18.55*** |
4.18 |
|
Total |
30- 1=29 |
154.8 |
|
|
|
***P
< 0.01, df 4, 25.
Table
- 12
Dunnet’s t test table against control for
Analgesic
activity
|
Statistic |
Pentazocine |
Chamomilla 3x
|
Chamomilla 30c
|
Chamomilla 0/3
|
|
t |
17.08****
|
5.59**** |
5.59**** |
13.44**** |
****P
< 0.001, df 25.
Table - 14
Analysis of variance table for Anti-Convulsant activity
after treatment.
|
Source of variation |
df |
Sum of squares |
Mean sum of squares |
F-ratio |
F-table value |
|
Treatment
Error |
5-1=4
29- 4=25 |
222.87
52.5 |
55.71
2.1 |
26.52*** |
4.18 |
|
Total |
30- 1=29 |
275.37 |
|
|
|
***P
< 0.01, df 4, 25.
Table
- 15
Dunnet’s t test table against control for Anti-Convulsant
activity
|
Statistic |
Phenytoin |
Chamomilla 3x
|
Chamomilla 30c
|
Chamomilla 0/3
|
|
t |
4.53****
|
1.73** |
1.58* |
2.96*** |
****P
< 0.001, *** P < 0.01, ** P < 0.1, *
P < 0.5, df 25.
Conclusion
In conclusion, the homoeopathic remedy, characterized by
infinitesimal doses and by dynamization according to Hahnemann’s
preparation technique has a marked informational character. The
possibility of storing information from molecules can be used
for therapeutical as well as experimental purpose.
The
result of the study justify the opportunity of future researches
concerning the intimate mechanism of inhibitory action on
central nervous system of Chamomilla homoeopathic potencies in
accordance with principle of similia.
References
-
Chamomilla, Homoeopathic
Pharmacopoeia of India, Vol- 5, Controller of
publications, Government of India, 1986, pp 22.
-
D’Amour, F.E and Smith, D.L;
J. Pharm.Exptl. Therap. 1941, 72: 74
-
Kulkarni,S.K; Life Sciences,
1980, 27 : 185 – 188
-
Eddy, N.B. and
Leimbach, D. J; J. Pharmacol. Exptl. Therap. 1953, 107:
385
-
Dewis, P.B; Brit. J. Pharmac.
Chemotherap.1953, 8 : 46
-
Kulkarni, S.K and Dandiya, P.C;
Indian J. Med. Res.1975, 63: 462-468
-
Misra, A.K; Dandiya, P.C and
Kulkarni, S.K; Indian J. Pharmac. 1973, 5 : 449-450
-
Kulkarni, S.K; Arch. Int.
Pharmacodyn.
1981, 252 : 124-132
-
Hahnemann. S. ‘Materia
Medica Pura’ Vol-1, reprint edition 1992,
B.Jain publishers
Pvt.Ltd,
pp.379-381
-
Guillemain, J. (1983) La recherché pharmacologique appliqué a
I’Homeopathie, sa grandeur, ses faiblesses, Homeop.Fr
71, pp.191 – 200.
-
Cristea A., Teodorescu – Negres.S, Darie.V et al “
Chamomilla Homoeopathic Dilution effect on Central Nervous
System – An Experimental pharmacological study”, Europ.
Neuropsychopharmacol.3,
pp. 446 – 447.
-
Richard Hughes ‘A
manual of pharmaco - dynamics’ 6 th reprint
edition 2001, B.Jain publishers Pvt.Ltd, pp. 382
|